NO971043L - Anvendelse av IL-4 for potensering av kjemoterapeutiske midler - Google Patents

Anvendelse av IL-4 for potensering av kjemoterapeutiske midler

Info

Publication number
NO971043L
NO971043L NO971043A NO971043A NO971043L NO 971043 L NO971043 L NO 971043L NO 971043 A NO971043 A NO 971043A NO 971043 A NO971043 A NO 971043A NO 971043 L NO971043 L NO 971043L
Authority
NO
Norway
Prior art keywords
chemotherapeutic agents
potentiation
radiation therapy
potentiating
cancer
Prior art date
Application number
NO971043A
Other languages
English (en)
Other versions
NO971043D0 (no
Inventor
Mary Ellen Rybak
Bertrand Coiffier
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO971043D0 publication Critical patent/NO971043D0/no
Publication of NO971043L publication Critical patent/NO971043L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

En fremgangsmåte for potensering av virkningen av kjemoterapeutiske midler eller strålingsterapi hos pattedyr rammet av cancer. Fremgangsmåten omfatter administrering av IL-4, enten i forbindelse med andre kjemoterapeutiske midler eller strålingsterapi.
NO971043A 1994-09-07 1997-03-06 Anvendelse av IL-4 for potensering av kjemoterapeutiske midler NO971043L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30192994A 1994-09-07 1994-09-07
US08/321,504 US5716612A (en) 1994-09-07 1994-10-12 Use of IL-4 for potentiation of chemotherapeutic agents
PCT/US1995/010988 WO1996007422A1 (en) 1994-09-07 1995-09-07 Use of il-4 for potentiation of chemotherapeutic agents

Publications (2)

Publication Number Publication Date
NO971043D0 NO971043D0 (no) 1997-03-06
NO971043L true NO971043L (no) 1997-05-06

Family

ID=26972669

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971043A NO971043L (no) 1994-09-07 1997-03-06 Anvendelse av IL-4 for potensering av kjemoterapeutiske midler

Country Status (14)

Country Link
US (1) US5716612A (no)
EP (1) EP0805688A1 (no)
JP (1) JPH09510737A (no)
CN (1) CN1157571A (no)
AU (1) AU3541295A (no)
CA (1) CA2199262A1 (no)
CZ (1) CZ68297A3 (no)
FI (1) FI970931A0 (no)
HU (1) HUT76665A (no)
MX (1) MX9701478A (no)
NO (1) NO971043L (no)
PL (1) PL319034A1 (no)
SK (1) SK30797A3 (no)
WO (1) WO1996007422A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074388A1 (en) * 2000-03-31 2001-10-11 Idec Pharmaceuticals Corporation Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma
CA2424345A1 (en) * 2000-10-16 2002-04-25 Neopharm, Inc. Liposomal formulation of mitoxantrone
EP1613261A4 (en) * 2003-04-09 2011-01-26 Novo Nordisk As INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES
US7932052B1 (en) * 2006-07-24 2011-04-26 The Regents Of The University Of Michigan Use of methanobactin
WO2017175200A1 (en) 2016-04-08 2017-10-12 The Regents Of The University Of California Modified hyaluronic acid hydrogels and proteins for the time-controlled release of biologic agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80678A (en) * 1985-11-19 1999-05-09 Schering Biotech Corp Human interleukin-4
US4958007A (en) * 1988-05-17 1990-09-18 Schering-Plough Corp. Extraction of human interleukin-4- from bacteria
KR100191223B1 (ko) * 1989-07-28 1999-06-15 둘락 노먼 씨. 인터루킨-4의 정제방법 및 이를 함유하는 약제학적 조성물
AU651059B2 (en) * 1989-10-31 1994-07-14 Schering Corporation E. coli secretory strains
WO1992004044A1 (en) * 1990-09-06 1992-03-19 Schering Corporation Use of il-4 to treat solid tumors
EP0490006B1 (en) * 1990-12-13 1994-06-22 Schering-Plough Pharmaceutical compositions for the treatment of B-cell malignancies
JPH05964A (ja) * 1991-06-19 1993-01-08 Tonen Corp 骨疾患治療薬及び高カルシウム血症治療薬

Also Published As

Publication number Publication date
WO1996007422A1 (en) 1996-03-14
AU3541295A (en) 1996-03-27
EP0805688A1 (en) 1997-11-12
FI970931A7 (fi) 1997-03-05
CZ68297A3 (en) 1997-10-15
US5716612A (en) 1998-02-10
CN1157571A (zh) 1997-08-20
JPH09510737A (ja) 1997-10-28
NO971043D0 (no) 1997-03-06
HUT76665A (en) 1997-10-28
MX9701478A (es) 1997-05-31
FI970931L (fi) 1997-03-05
SK30797A3 (en) 1997-11-05
FI970931A0 (fi) 1997-03-05
PL319034A1 (en) 1997-07-21
CA2199262A1 (en) 1996-03-14

Similar Documents

Publication Publication Date Title
DE69027057D1 (de) Retinal, dessen Derivate und deren therapeutische Verwendung
NO305886B1 (no) Anvendelse av et organisk nitritt for fremstilling av medikamenter for kontinuerlig, vasodilatorisk terapi
FI925892L (fi) Pulverformiga, tvaerbundna polymerer, som absorberar vattenhaltiga vaetskor och blod, foerfarande foer framstaellning av dessa och anvaendning av dessa som absorptionsmedel i sanitetsprodukter
ITRM920412A0 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiegoterapeutico.
NO975661L (no) Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer
IS4923A (is) Meðferðaráform við inngjöf á H+,K+-ATPasa-blokkara
NO954878L (no) Pyrrolderivater
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
FI930633A7 (fi) Bensimidatsolijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
FI931414A7 (fi) Imidatsolijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
DE59100216D1 (de) Zerlegbare spurtraegerbruecke mit zwischen den spurtraegern angeordnetem vorbautraeger.
NO890046L (no) Disubstituerte pyridiner.
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
AU4445089A (en) Lactamimides in the treatment of drug-resistant protozoal infections
NO971043L (no) Anvendelse av IL-4 for potensering av kjemoterapeutiske midler
ATE133680T1 (de) Oligosaccharidderivate und deren verwendung in heilmitteln
AU8447991A (en) Antineoplastic effect potentiator and antineoplastic agent
EP0370300A3 (de) Cyclopropyl-Substituierte Azolylmethylcarbinole, Verfarhren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
FI883484A7 (fi) Bentsimidatsolijohdannaiset, niiden valmistus ja käyttö terapiassa.
EP1287832A3 (en) Use of leukemia inhibitory factor antagonist
NO913187L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.
SE9602262D0 (sv) New use of derivatives of cystine
NO985325L (no) Anvendelse av substituert azaspiran ved behandling av astma
IT1263076B (it) Uso orale e topico della n-acetil-5-metossitriptamina (melatonina) nella terapia della psoriasi volgare.
UA32057A (uk) Спосіб лікування кератоувеїтів різної етіології

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application